By integrating technologies and managing data effectively, he has improved data integrity, efficiency, and traceability in laboratories crucial for drug synthesis and quality control.
SAN MATEO, CA, June 19, 2024 /24-7PressRelease/ — Michael S. Louie, PhD, has been included in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Louie is a distinguished expert in digital information for life sciences, currently serving as the senior vice president of digital transformation and chief information officer at Kodiak Sciences. With almost four decades of professional experience, he has dedicated the past two years to enhancing business processes through automation and digital transformation. His primary responsibilities include assessing business processes to identify opportunities for efficiency improvements by implementing user-friendly software tools that facilitate information management, innovation and drug development.
Prior to his current role, Dr. Louie held several significant positions at Gilead Sciences. From 2019 to 2022, he was the vice president of analytical operations and information systems, where he played a crucial role in integrating technologies to improve data integrity and efficiency. He previously served as the vice president of information technology from 2016 to 2019 and as the senior director of information technology from 2010 to 2016. His earlier roles there include director of IT quality, security, and compliance from 2006 to 2010; associate director of information technology from 1998 to 2006; and research scientist from 1993 to 1998.
Before he joined Gilead Sciences, Dr. Louie worked as a scientist at Monsanto from 1992 to 1993 and as an analytical chemist at Syntex Corporation from 1986 to 1987. His initial professional experience was as an organic chemist at Shell Agricultural Biological Sciences Research Center from 1985 to 1986.
Dr. Louie’s most significant achievement lies in laboratory automation within the life sciences industry. By integrating technologies and managing data effectively, he has improved data integrity, efficiency, and traceability in laboratories crucial for drug manufacturing, quality control and supply chain operations. This accomplishment ensures the availability of high-quality drugs and prevents drug shortages, playing a critical role in patient safety.
In addition to his professional achievements, Dr. Louie has made notable contributions through presentations at industry conferences such as the Veeva Systems R&D Conference. He is also an active member of the International Society for Pharmaceutical Engineering and the American Chemical Society. His involvement with industry coalitions and the Food and Drug Administration in developing artificial intelligence (AI) guidelines for machines in the industry further underscores his commitment to advancing technological standards.
Dr. Louie’s educational background laid a strong foundation for his career success. He earned a Bachelor of Science in biochemistry from the University of California Davis and a Doctorate in Chemistry from the University of California Riverside. He also attributes much of his success to the mentorship he received throughout his career. By actively seeking out guidance from supervisors and senior executives, he gained valuable insights into skill sets crucial for success in his field. This mentorship also led him to explore innovative uses of AI, such as developing models based on biometric imagery for diagnosis and treatment of diseases like Alzheimer’s, diabetes, cardiovascular, liver and retinal diseases.
Looking ahead, Dr. Louie aims to further his journey in AI and model development over the next five years as he has transitioned into advisory roles. He plans to collaborate with diverse groups to offer insights on developing machine learning models to drive efficiency in disease management and operational excellence. He sees immense potential for innovation by employing non-invasive diagnostic approaches.
About Marquis Who’s Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America®, Marquis Who’s Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who’s Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who’s Who® website, www.marquiswhoswho.com.
# # #
